Literature DB >> 22147998

Comparison of clinico-physiologic and CT imaging risk factors for COPD exacerbation.

Jung-Wan Yoo1, Yoonki Hong, Joon Beom Seo, Eun Jin Chae, Seung Won Ra, Ji-Hyun Lee, Eun Kyung Kim, Seunghee Baek, Tae-Hyung Kim, Woo Jin Kim, Jin Hwa Lee, Sang-Min Lee, Sangyeub Lee, Seong Yong Lim, Tae Rim Shin, Ho Il Yoon, Seung Soo Sheen, Jae Seung Lee, Jin Won Huh, Yeon-Mok Oh, Sang-Do Lee.   

Abstract

To date, clinico-physiologic indices have not been compared with quantitative CT imaging indices in determining the risk of chronic obstructive pulmonary disease (COPD) exacerbation. We therefore compared clinico-physiologic and CT imaging indices as risk factors for COPD exacerbation in patients with COPD. We retrospectively analyzed 260 COPD patients from pulmonary clinics at 11 hospitals in Korea from June 2005 to November 2009 and followed-up for at least one year. At the time of enrollment, none of these patients had COPD exacerbations for at least 2 months. All underwent clinico-physiologic and radiological evaluation for risk factors of COPD exacerbation. After 1 yr, 106 of the 260 patients had at least one exacerbation of COPD. Multiple logistic regression analysis showed that old age, high Charlson Index, and low FEV(1) were significant in a clinico-physiologic model, with C-statistics of 0.69, and that increased age and emphysema index were significant in a radiologic model, with C-statistics of 0.64. The difference between the two models was statistically significant (P = 0.04 by bootstrap analysis). Combinations of clinico-physiologic risk factors may be better than those of imaging risk factors in predicting COPD exacerbation.

Entities:  

Keywords:  Computed Tomography; Exacerbation; Pulmonary Disease, Chronic Obstructive; Risk Factors

Mesh:

Year:  2011        PMID: 22147998      PMCID: PMC3230021          DOI: 10.3346/jkms.2011.26.12.1606

Source DB:  PubMed          Journal:  J Korean Med Sci        ISSN: 1011-8934            Impact factor:   2.153


  30 in total

1.  The costs of exacerbations in chronic obstructive pulmonary disease (COPD).

Authors:  F Andersson; S Borg; S A Jansson; A C Jonsson; A Ericsson; C Prütz; E Rönmark; B Lundbäck
Journal:  Respir Med       Date:  2002-09       Impact factor: 3.415

2.  Risk indexes for exacerbations and hospitalizations due to COPD.

Authors:  Dennis E Niewoehner; Yuliya Lokhnygina; Kathryn Rice; Ware G Kuschner; Amir Sharafkhaneh; George A Sarosi; Peter Krumpe; Karen Pieper; Steven Kesten
Journal:  Chest       Date:  2007-01       Impact factor: 9.410

3.  Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease.

Authors:  T A Seemungal; G C Donaldson; A Bhowmik; D J Jeffries; J A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  2000-05       Impact factor: 21.405

4.  Costs of chronic bronchitis and COPD: a 1-year follow-up study.

Authors:  Marc Miravitlles; Cristina Murio; Tina Guerrero; Ramon Gisbert
Journal:  Chest       Date:  2003-03       Impact factor: 9.410

5.  Clinical analysis of chronic obstructive pulmonary disease phenotypes classified using high-resolution computed tomography.

Authors:  Keisaku Fujimoto; Yoshiaki Kitaguchi; Keishi Kubo; Takayuki Honda
Journal:  Respirology       Date:  2006-11       Impact factor: 6.424

6.  Mortality after hospitalization for COPD.

Authors:  Pedro Almagro; Esther Calbo; Anna Ochoa de Echagüen; Bienvenido Barreiro; Salvador Quintana; José L Heredia; Javier Garau
Journal:  Chest       Date:  2002-05       Impact factor: 9.410

7.  Comparison of computed density and macroscopic morphometry in pulmonary emphysema.

Authors:  P A Gevenois; V de Maertelaer; P De Vuyst; J Zanen; J C Yernault
Journal:  Am J Respir Crit Care Med       Date:  1995-08       Impact factor: 21.405

8.  Standardization of Spirometry, 1994 Update. American Thoracic Society.

Authors: 
Journal:  Am J Respir Crit Care Med       Date:  1995-09       Impact factor: 21.405

9.  Lower respiratory illnesses promote FEV(1) decline in current smokers but not ex-smokers with mild chronic obstructive pulmonary disease: results from the lung health study.

Authors:  R E Kanner; N R Anthonisen; J E Connett
Journal:  Am J Respir Crit Care Med       Date:  2001-08-01       Impact factor: 21.405

Review 10.  Corticosteroid therapy for patients with acute exacerbations of chronic obstructive pulmonary disease: a systematic review.

Authors:  J M Singh; V A Palda; M B Stanbrook; K R Chapman
Journal:  Arch Intern Med       Date:  2002 Dec 9-23
View more
  9 in total

1.  Comorbidities of chronic obstructive pulmonary disease in Koreans: a population-based study.

Authors:  Hyejin Joo; Jinkyeong Park; Sang Do Lee; Yeon-Mok Oh
Journal:  J Korean Med Sci       Date:  2012-07-25       Impact factor: 2.153

2.  Study Design and Outcomes of Korean Obstructive Lung Disease (KOLD) Cohort Study.

Authors:  Tai Sun Park; Jae Seung Lee; Joon Beom Seo; Yoonki Hong; Jung-Wan Yoo; Byung Ju Kang; Sei Won Lee; Yeon-Mok Oh; Sang-Do Lee
Journal:  Tuberc Respir Dis (Seoul)       Date:  2014-04-25

3.  Clinical and pulmonary functions profiling of patients with chronic obstructive pulmonary disease experiencing frequent acute exacerbations.

Authors:  Prem Parkash Gupta; Manjunath B Govidagoudar; Rohtas Yadav; Dipti Agarwal
Journal:  Lung India       Date:  2018 Jan-Feb

Review 4.  CT densitometry in emphysema: a systematic review of its clinical utility.

Authors:  Diana Crossley; Mary Renton; Muhammad Khan; Emma V Low; Alice M Turner
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-02-07

5.  A novel CT-emphysema index/FEV1 approach of phenotyping COPD to predict mortality.

Authors:  Li-Cher Loh; Choo-Khoon Ong; Hyun-Jung Koo; Sang Min Lee; Jae-Seung Lee; Yeon-Mok Oh; Joon-Beom Seo; Sang-Do Lee
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-08-22

6.  Developing a Machine Learning Model to Predict Severe Chronic Obstructive Pulmonary Disease Exacerbations: Retrospective Cohort Study.

Authors:  Siyang Zeng; Mehrdad Arjomandi; Yao Tong; Zachary C Liao; Gang Luo
Journal:  J Med Internet Res       Date:  2022-01-06       Impact factor: 5.428

7.  Automatically Explaining Machine Learning Predictions on Severe Chronic Obstructive Pulmonary Disease Exacerbations: Retrospective Cohort Study.

Authors:  Siyang Zeng; Mehrdad Arjomandi; Gang Luo
Journal:  JMIR Med Inform       Date:  2022-02-25

8.  Phenotyping COPD Patients with Emphysema Distribution Using Quantitative CT Measurement; More Severe Airway Involvement in Lower Dominant Emphysema.

Authors:  Jisoo Park; Eun-Kyung Kim; Se Hee Lee; Mi-Ae Kim; Jung-Hyun Kim; Sang Min Lee; Jae Seung Lee; Yeon-Mok Oh; Sang-Do Lee; Ji-Hyun Lee
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2022-08-31

9.  Efficacy and Safety of Roflumilast in Korean Patients with COPD.

Authors:  Jae Seung Lee; Yoon Ki Hong; Tae Sun Park; Sei Won Lee; Yeon Mok Oh; Sang Do Lee
Journal:  Yonsei Med J       Date:  2016-07       Impact factor: 2.759

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.